Atrial fibrillation trials in Uzbekistan

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  Safety and Performance of ENDOMATIC SEPIOLA Left Atrial Appendage (LAA) Closure Device

  Where

  Tashkent

  Age

  18 years and over

  People

  15 worldwide

  Run by

  Endomatic Ltd.

  See details and how to joinNCT06099106